Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Accuray Inc (ARAY)

Accuray Inc (ARAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Accuray Inc 1240 Deming Way MADISON WI 53717 USA

www.accuray.com P: 608-824-2800

Description:

Accuray Inc. designs, develops & sells radiosurgery and radiation therapy systems for treatment of tumors in the body. The company's product suite includes the CyberKnife Systems and the TomoTherapy Systems. It primarily generates revenues by selling the CyberKnife & TomoTherapy Systems and providing ongoing services and upgrades to customers following installation of the CyberKnife System. Product revenues include sales of linacs for other uses. It also offers optional hardware and software, technical enhancements and upgrades to the CyberKnife & TomoTherapy System. The CyberKnife Systems include: the CyberKnife G4, CyberKnife VSI System and the new CyberKnife M6 Series System. TomoTherapy Systems include the Hi-Art System, delivering CT-guided, helical intensity modulated radiation therapy; the TomoHD System and the Tomo H Series Systems.

Key Statistics

Overview:

Market Capitalization, $K 218,172
Enterprise Value, $K 299,802
Shares Outstanding, K 99,169
Annual Sales, $ 447,610 K
Annual Net Income, $ -9,280 K
Last Quarter Sales, $ 107,240 K
Last Quarter Net Income, $ -9,620 K
EBIT, $ 110 K
EBITDA, $ 5,560 K
60-Month Beta 1.44
% of Insider Shareholders 3.78%
% of Institutional Shareholders 64.08%
Float, K 95,420
% Float 96.22%
Short Volume Ratio 0.57

Growth:

1-Year Return -22.20%
3-Year Return -53.19%
5-Year Return -48.96%
5-Year Revenue Growth 10.55%
5-Year Earnings Growth 64.29%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.10 on 01/31/24
Latest Earnings Date 05/01/24 [AMC]
Earnings Per Share ttm -0.15
EPS Growth vs. Prev Qtr -233.33%
EPS Growth vs. Prev Year -400.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

ARAY Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -28.12%
Return-on-Assets % -3.05%
Profit Margin % -2.07%
Debt/Equity 3.53
Price/Sales 0.49
Price/Cash Flow N/A
Price/Book 4.42
Book Value/Share 0.49
Interest Coverage -0.93
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar